Gene Query: UBE2J1

Dataset Description Geneva Score
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 57.42
Global expression profiles in cardiac progenitor cells generated by ISX-9 57.42
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 43.76
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 42.5
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 40.73
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 38.76
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 38.76
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 38.14
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 37.93
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 37.39
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 37.35
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 35.83
Gene expression changes upon drug withdrawal (Mel888 cell line) 35.43
Total RNA-seq in ALL-SIL upon JQ1 inhibition 33.08
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 27.39
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 26.28
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 25.67
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 25.43
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 25.43
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 25.24
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 25.05
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 24.5
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 24.5
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 24.35
BET bromodomain inhibition 24.35
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 23.9
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 23.9
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 23.78
LNCaP treated with iBET 23.51
Molecular Mechanisms of Endothelial Hyperpermeability 23.47
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 22.29
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 22.29
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 22.15
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 22.02
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 21.72
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 21.72
Paxillin regulates genomic networks in prostate cancer [C4-2] 21.49
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 20.74
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 20.39
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 20.13
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 20.12
RNAseq analysis of ESRP regulated splicing events in prostate cancer 20.02
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 19.86
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 19.64
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 19.17
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 19.04
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 19.03
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 19.0
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 18.85
Gene expression analysis of dengue-infected cells 18.82
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 18.81
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 18.41
An optimization system for isolating and sequencing of single human colon cancer cells 18.28
Role for citron kinase in prostate cancer growth 18.18
CD74 role in transcription regulation [RNA-seq] 17.77
CD74 role in transcription regulation 17.77
Cleavage Factor Im as a key regulator of 3’ UTR length 17.74
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 17.54
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 17.45
Differentially expressed vascular development genes for iPSC-ECs from CDI 17.33
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 17.27
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 17.12
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 16.99
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 16.87
Transcriptome analysis of SKI knock-out in HL60 cells 16.87
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 16.67
Identification of the role of polydom in neurofibromas 16.62
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 16.33
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 16.32
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 16.29
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 16.25
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 16.05
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 15.63
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 15.61
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 15.6
Cerebellar differentiation in Ataxia-Telangiectasia 15.56
MYC dependent mRNA translation shapes gene expression and cell biology 15.36
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 15.26
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 15.22
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 15.15
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 15.08
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 15.08
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 14.89
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 14.61
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 14.54
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 14.53
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 14.47
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 14.47
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 14.43
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 14.35
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 14.27
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 14.27
Human cells contain natural double-stranded RNAs with potential regulatory capacity 14.25
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 14.25
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 14.2
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 14.19
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 13.96
Transcriptomic analyssis following EHMT1/2 inhibition 13.95
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 13.86
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 13.82
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 13.75
Functional role of SLIT2 and ROBO1 in trophoblasts 13.74
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 13.69
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 13.61
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 13.57
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 13.35
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 13.35
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 13.33
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 13.33
RNA-seq of YB5 cells treated with Proscillaridin A 13.28
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 13.26
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 13.22
Transcriptional profiles of normal human mature B cells 13.22
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 13.21
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 13.21
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 13.17
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 13.03
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 13.01
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 12.92
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 12.75
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 12.65
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 12.65
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 12.61
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 12.59
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 12.57
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 12.57
STRIPAK directs PP2A activity to promote oncogenic transformation 12.56
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 12.48
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 12.48
Gene expression in PANC1 cells treated with Rakicidin 12.42
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 12.42
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 12.41
Lineage specific differentiation is influenced by state of human pluripotency 12.4
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 12.4
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 12.38
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 12.34
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 12.14
RNA-Seq with and without RNase treatment in PCa cell lines 12.06
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 11.95
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 11.78
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 11.78
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 11.77
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 11.7
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 11.7
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 11.66
Transcriptome of diurnal human blood neutrophils 11.61
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 11.57
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 11.54
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 11.5
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 11.5
Next generation sequencing of small RNAs isolated from exosomes in human semen 11.48
Total RNA-seq in ALL-SIL upon TLX1 knockdown 11.44
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 11.41
Genome wide expression change in LCC2 and MCF-7 cells 11.41
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 11.35
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 11.32
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 11.24
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 11.15
Genome-wide analysis of Dengue virus 2 infected cells 11.12
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 11.05
RNAseq of T-ALL upon long non coding rna purturbation 10.94
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 10.9
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 10.85
PNET animal model: new insights (II) 10.78
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 10.76
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 10.76
HNRNPM-regulated splicing dependencies in prostate cancer 10.74
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 10.74
MYCi361 regulates MYC target genes 10.73
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 10.56
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 10.45
Survival of pancreatic cancer cells lacking KRAS function 10.36
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 10.35
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 10.32
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 10.3
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 10.25
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 10.22
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 10.2
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 10.15
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 10.09
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 10.01
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 9.94
Tyrosine Kinase Inhibitor Cardiotoxicity 9.94
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 9.94
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 9.9
Postnatal lipids drive hepatocyte maturation 9.86
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 9.82
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 9.78
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 9.77
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 9.64
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 9.63
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 9.62
The Genomic Landscape of Atypical Fibroxanthoma 9.61
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 9.58
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 9.57
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 9.57
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 9.54
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 9.53
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 9.46
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 9.46
The human blood-nerve barrier transcriptome 9.44
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 9.43
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 9.41
Differential analysis of gene regulation at transcript resolution by RNA-Seq 9.34
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 9.34
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 9.31
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 9.25
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 9.24
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 9.23
FBXW7 modulates stress response by post-translational modification of HSF1 9.23
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 9.18
IRF2 is a master regulator of human keratinocyte stem cell fate 9.18
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 9.16
Co-transcriptional loading of RNA export factors shapes the human transcriptome 9.16
RNAseq of HEK293 cells after Chtop knockdown 9.16
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 9.15
Disruption of the exocyst induces podocyte loss and dysfunction 9.15
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 9.14
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 9.14
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 9.11
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 9.04
Ectoderm specification of H1 human embryonic stem cells 9.02
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 9.02
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 8.94
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 8.85
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 8.83
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 8.83
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 8.83
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 8.81
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 8.8
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 8.79
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 8.75
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 8.75
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 8.75
ARID1A and ARID1B loss in HCT116 cells 8.74
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 8.73
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 8.73
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 8.72
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 8.66
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 8.66
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 8.65
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 8.64
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 8.61
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.56
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 8.55
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 8.55
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 8.53
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 8.53
Short and Long RNA sequencing of human mature erythrocytes 8.52
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 8.52
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 8.5
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 8.49
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 8.49
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 8.45
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 8.41
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 8.4
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 8.4
TCF7L1 knockdown in pancreatic cancer 8.38
Transcriptome wide analysis of classically and alternatively activated macrophages 8.33
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 8.32
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 8.32
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 8.27
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 8.27
Regulation of Lipids is Central to Replicative Senescence 8.12
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 8.05
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 8.05
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 7.98
SLIGRL-induced gene expression changes in NHEK cells 7.96
Cajal bodies are linked to genome conformation [RNA-Seq] 7.92
Cajal bodies are linked to genome conformation 7.92
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 7.88
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 7.88
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 7.86
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 7.84
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 7.83
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 7.81
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 7.81
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 7.81
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 7.79
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 7.75
iPSC-Derived Cholangiocytes 7.73
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 7.72
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 7.72
RNA Seq of HMVEC under hypoxia 7.65
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 7.65
Functional role of CPPED1 in trophoblasts. 7.64
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 7.62
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 7.62
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 7.6
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 7.6
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 7.54
Ro60-knockout cells 7.53
CDK4/6 inhibitor resistance in prostate cancer 7.49
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 7.49
single cell RNA-seq from GM12878 (ENCSR673UIY) 7.45
Targeted enhancer activation by a subunit of the integrator complex 7.4
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 7.22
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 7.19
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 7.16
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 7.1
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 7.02
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 6.99
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 6.93
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 6.9
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 6.86
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 6.79
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 6.68
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 6.65
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 6.65
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 6.63
Identification of long noncoding RNAs in T-ALL cell lines 6.58
miR941 overexpression experiment 6.57
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 6.52
Paxillin regulates genomic networks in prostate cancer [LNCaP] 6.44
BACH2 in human plasma cell fate decision 6.43
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 6.32
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 6.32
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 6.3
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 6.28
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 6.2
Solid phase chemistry to covalently and reversibly capture thiolated RNA 6.18
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 6.18
Epigenome regulation during epidermal lineage commitment [RNA-seq] 6.18
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 6.16
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 6.14
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 6.14
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 6.13
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 6.13
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 6.05
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 5.98
MEIS1 regulates hematopoiesis in hPSCs 5.92
Toxoplasma gondii infection of human retinal pigment epithelial cells 5.82
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 5.79
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 5.79
SRSF1 role in cellular gene expression and splicing 5.77
Defective structural RNA processing in relapsing-remitting multiple sclerosis 5.75
Trans-differentiation of human adult peripheral blood T cells into neurons 5.74
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 5.67
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 5.65
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 5.62
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 5.61
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 5.59
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 5.52
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 5.37
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 5.29
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 5.17
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 5.13
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 5.11
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 5.1
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 5.1
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 5.09
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 5.03
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 5.03
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 5.02
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 5.01
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 4.94
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 4.93
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 4.93
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 4.89
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 4.82
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 4.62
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 4.56
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 4.56
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 4.56
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 4.46
FOXP1 orchestration of ASD-relevant signaling pathways. 4.41
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 4.4
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 4.35
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 4.31
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 4.22
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 4.22
SLAM-seq for K562 endogenous mRNA decay 4.16
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 4.14
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 4.14
Transcriptomes of human monocytes after ex vivo exposure to uric acid 4.1
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 4.1
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 4.06
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 4.06
Transcriptome analysis of CNS leukemia 3.94
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 3.94
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.9
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 3.75
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 3.7
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 3.67
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 3.66
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 3.52
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 3.49
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 3.49
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 3.45
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 3.44
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 3.37
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 3.34
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 3.33
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 3.29
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 3.25
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.24
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 3.22
RNA editing in nascent RNA affects pre-mRNA splicing 3.19
Effects of rFVIIIFc on human macrophages 3.15
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 3.09
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 2.98
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 2.98
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.98
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 2.94
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 2.93
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 2.93
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 2.91
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 2.9
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 2.89
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 2.71
Interaction between mitoNEET and NAF-1 in cancer cells 2.64
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 2.62
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.56
Regulation of hypoxia-inducible factor activity by ZMYND8 2.55
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.54
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 2.43
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 2.38
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 2.36
Measure transcript integrity using RNA-seq data 2.34
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 2.33
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 2.26
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 2.25
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 2.23
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 2.16
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.09
A novel target of EZH1/2 for treatment of mantle cell lymphoma 2.06
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.01
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.98
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.97
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 1.95
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.94
Effects of transcription on genome - nuclear lamina interactions 1.94
Electronic cigarettes 1.72
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 1.7
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 1.7
hESC neural differentiation 1.69
RNA-seq analysis of gene expression patterns during hESC neural differentiation 1.69
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.61
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 1.58
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 1.57
Age-Related Gene Expression Changes in Prostate Cancer Patients 1.57
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.57
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 1.41
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 1.32
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 1.26
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.23
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.22
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 1.1
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 1.1
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.09
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 1.08
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.05
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.02
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 1.02
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.98
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.98
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 0.96
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.88
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 0.88
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.87
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.87
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.86
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 0.85
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.84
Generation and functional characterization of MDSC-like cells 0.83
Transcriptome analysis of peripheral blood monocytes 0.79
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.76
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.75
Gene expression activation in CLL mediated by MSCs contact 0.73
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.7
High-resolution comparative analysis of great ape genomes 0.58
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 0.54
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.47
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.43
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.39
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.37
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.36
SOX11 knockdown in B-ALL cell lines 0.34
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.29
Expression data from miR340 overexpressing human A549 cells 0.29
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 0.28
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.27
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.27
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 0.25
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.23
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.2
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.2
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.19
The role of m6A/m-RNA methylation in stress response regulation 0.13
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.13
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.11
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.1
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 0.08
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 0.08
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.04
Expression analysis of the TAF1 syndrome 0.04
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.04
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.04
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 0.02
Transcription elongation regulates genome 3D structure 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation